In comparison with the above-mentioned variables, the recipients’ IL6-174 polymorphism remained to be an independent significant risk factor for the occurrence of acute GVHD (P = 0.030) and chronic GVHD (P = 0.045). Here, IL6 is linked to acute graft versus host disease.